Amneal announces approval and launch of generic isoproterenol hydrochloride injection
Amneal Pharmaceuticals announced that it has received FDA approval for a generic version of IsuprelTM Injection (isoproterenol hydrochloride) USP, 0.2 mg/mL and 1 mg/5 mL(0.2 mg/mL) Single-Dose Vials. The Company has immediately initiated commercialization activities. October 19, 2018